Company Directory > Biotech > IBSA Institut Biochimique SA
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IBSA Institut Biochimique SA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical company founded in 1945 and headquartered in Lugano, Switzerland. The company specializes in the research, development, and production of pharmaceutical products, medical devices, and food supplements, with a strong focus on innovative drug delivery systems, such as orodispersible films and advanced injectable formulations. IBSA operates in over 90 countries with 20 subsidiaries across Europe, China, and the United States. It is recognized as a global leader in reproductive medicine and hyaluronic acid-based products, maintaining a diverse portfolio across 10 therapeutic areas including endocrinology, pain management, osteoarticular health, aesthetic medicine, and dermatology.
CLASSIFICATION
Company Type:Biotech
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B+
Founded:1945
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Peptide Hormone, Hyaluronic acid-based products
Active Trials:110
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:IBSA Farmaceutici (Italy), IBSA Pharma (various regions)
COMPETITION
Position:Niche Player
Competitors:Synthego, Sutro Biopharma, Avidity Biosciences
LEADERSHIP
Key Executives:
Arturo Licenziati - President and CEO
LINKS
Website:ibsa.ch
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IBSA Institut Biochimique SA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.